Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"In situ cross-docking" to simultaneously address multiple targets.

Christoph A Sotriffer1, Ingo Dramburg

  • 1Department of Pharmaceutical Chemistry, University of Marburg, Marbacher Weg 6, D-35032 Marburg, Germany. sotriffer@staff.uni-marburg.de

Journal of Medicinal Chemistry
|April 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controlling Supramolecular Structures of Drugs by Light.

Molecular pharmaceutics·2020
Same author

11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015.

Journal of cheminformatics·2017
Same author

Empirical Scoring Functions for Affinity Prediction of Protein-ligand Complexes.

Molecular informatics·2016
Same author

Development, synthesis and structure-activity-relationships of inhibitors of the macrophage infectivity potentiator (Mip) proteins of Legionella pneumophila and Burkholderia pseudomallei.

Bioorganic & medicinal chemistry·2016
Same author

Correlating Drug-Target Kinetics and <i>In vivo</i> Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP Reductase.

Chemical science·2016
Same author

Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.

Journal of computer-aided molecular design·2016

This study introduces in situ cross-docking, a novel method allowing simultaneous protein target analysis in one docking run. This approach significantly saves time compared to traditional methods by enabling direct ligand selection of the optimal target.

Area of Science:

  • Computational chemistry
  • Structural biology
  • Drug discovery

Background:

  • Standard molecular docking requires individual calculations for each protein target.
  • This presents a bottleneck in high-throughput screening and drug development pipelines.

Purpose of the Study:

  • To develop a novel docking approach for simultaneous analysis of multiple protein targets.
  • To reduce computational time and enhance efficiency in molecular docking workflows.

Main Methods:

  • The study presents an "in situ cross-docking" method.
  • This approach utilizes a grid-based docking technique, merging grids from individual binding sites into a single, unified grid.
  • Ligands can directly select the optimal target during the docking process.

Related Experiment Videos

Main Results:

  • The in situ cross-docking method is technically feasible.
  • This approach allows for simultaneous docking against multiple protein targets in a single run.
  • Significant time savings are achievable compared to conventional cross-docking methods.

Conclusions:

  • In situ cross-docking offers a more efficient alternative to standard docking protocols.
  • This method has the potential to accelerate drug discovery by streamlining the identification of lead compounds.
  • The simultaneous analysis of multiple targets enhances the overall throughput of virtual screening.